Evaluation of dose-related effects of aspirin on platelet function - Results from the aspirin-induced platelet effect (ASPECT) study
Evaluation of dose-related effects of aspirin on platelet function - Results from the aspirin-induced platelet effect (ASPECT) study
复制标题
DOI:
10.1161/circulationaha.106.675587
复制
发表时间:
2007-06-26
期刊:
影响因子:
37.8
通讯作者:
Tantry, Udaya S.
中科院分区:
文献类型:
--
作者:
Gurbel, Paul A.;Bliden, Kevin P.;Tantry, Udaya S.
Background - The antiplatelet effect of aspirin is attributed to platelet cyclooxygenase-1 inhibition. Controversy exists on the prevalence of platelet resistance to aspirin in patients with coronary artery disease and effects of aspirin dose on inhibition. Our primary aim was to determine the degree of platelet aspirin responsiveness in patients, as measured by commonly used methods, and to study the relation of aspirin dose to platelet inhibition.Methods and Results - We prospectively studied the effect of aspirin dosing on platelet function in 125 stable outpatients with coronary artery disease randomized in a double-blind, double-crossover investigation (81, 162, and 325 mg/d for 4 weeks each over a 12-week period). At all doses of aspirin, platelet function was low as indicated by arachidonic acid (AA)-induced light transmittance aggregation, thrombelastography, and VerifyNow. At any 1 dose, resistance to aspirin was 0% to 6% in the overall group when AA was used as the agonist, whereas it was 1% to 27% by other methods [collagen and ADP-induced light transmittance aggregation, platelet function analyzer (PFA-100)]. Platelet response to aspirin as measured by collagen-induced light transmittance aggregation, ADP-induced light transmittance aggregation, PFA-100 (81 mg versus 162 mg, P